Quinn Opportunity Partners »

Halozyme Therapeutics shares owned by Quinn Opportunity Partners

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Quinn Opportunity Partners from 13F filings

Historical chart of Quinn Opportunity Partners investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Quinn Opportunity Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Quinn Opportunity Partners

Quarter filed Position value Share count Share price at filing
2025-06-30 $312k 6.0k 52.02
2025-03-31 $447k 7.0k 63.81
2024-12-31 $598k 13k 47.81